Search results
Found 19893 matches for
PANORAMIC hits the 20,000 participant milestone
31 March 2022
The world’s largest study of community-based treatments for acute COVID-19 has reached a world-first, historic milestone: over twenty thousand participants from across the UK have now taken part in the PANORAMIC trial.
Preventing long-term pain from shingles
30 March 2022
About one in three people get shingles, which causes a painful rash. Researchers are recruiting patients with newly diagnosed shingles into a new study, to see if they can prevent the long-term pain which commonly persists after the rash has healed.
Removal of prominent displays in-store reduces hike in Easter chocolate sales
24 March 2022
Banning prominent in-store displays of Easter eggs and seasonal confectionery could help reduce calories in shopping baskets, according to an independent evaluation by researchers at the University of Oxford. The team worked with a large UK food retailer who removed end-of-aisle and store entrance freestanding promotional displays of seasonal chocolate in a sample of stores, for seven weeks before Easter 2019. They found a significant attenuation of the usual seasonal increase in confectionery sales in these intervention stores compared to control stores.
Oxford launches new Bennett Institute for Applied Data Science and Ben Goldacre announced as the first Bennett Professor of Evidence-Based Medicine
- Awards & appointments
- Bennett Institute
- Evidence-Based Health Care
- Infection, Respiratory and Acute Care
23 March 2022
The use of data, evidence and digital tools in healthcare and policy takes a major stride forward with the official launch of the Bennett Institute for Applied Data Science and appointment of Ben Goldacre as Bennett Professor of Evidence-Based Medicine
NDPCHS Professors Susan Jebb and Paul Aveyard lead new project to help people into remission from type 2 diabetes
17 March 2022
Researchers from Nuffield Department of Primary Care Health Sciences are to lead a new £2.2 million project aimed at giving more people newly diagnosed with type 2 diabetes the chance of going into remission.
Blood tests provide no additional information to FIT alone when prioritising patients for colorectal cancer referral
15 March 2022
Faecal immunochemical testing (FIT) alone leads to the identification of the same number of patients with colorectal cancer as more complicated approaches that combine the FIT result with the results of commonly used blood tests.
An online programme to reduce meat intake
4 March 2022
A bespoke website to support people to eat less meat helped frequent meat eaters to halve their meat consumption over just nine weeks. The trial, run by researchers in the Livestock, Environment and People (LEAP) programme at the University of Oxford, found the programme to be popular with participants who felt it supported them to change their dietary habits. The work is published in the European Journal of Nutrition.
New NIHR Senior Investigator appointed in NDPCHS
3 March 2022
Professor Julia Hippisley-Cox joins the NIHR college of senior research leaders
Oxford-led research makes BJGP's top ten most read and published research articles of 2021
- Awards & appointments
- Digital health & innovation
- Health Services Research
- Patient experience
- QResearch
15 February 2022
Four articles, led or co-authored by Oxford researchers in the department, make the BMJ's top 10 list for the most read and published articles of 2021.
In helping smokers quit, combining treatments is key
10 February 2022
A new clinical review provides guidance to physicians and the public about the most effective tobacco cessation treatments.
Expanding meat-free offering can reduce meat purchases: an observational study
31 January 2022
Boosting the number of plant-based options can be an effective way of encouraging people to choose them and reducing meat purchase and consumption. New research finds that increasing the ratio of meat-free to meat-based meals in canteens could be a simple intervention to promote more sustainable food purchases, and is published in the International Journal of Behavioral Nutrition and Physical Activity.
COVID-19 infection more likely than vaccines to cause rare cardiovascular complications
16 December 2021
Led by the University of Oxford, a team of UK-based researchers have today reported results of the largest ever study to compare the risks of cardiovascular events, such as myocarditis, pericarditis, and cardiac arrhythmia, between different vaccines and COVID-19 infection, and the first to investigate the association between cardiac events and the Oxford-AstraZeneca vaccine.
Recruitment begins for national community COVID-19 antiviral trial
8 December 2021
Researchers from the University of Oxford have today started recruiting participants for a first-of-its-kind clinical trial to test novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 and those who are at higher risk of complications – partnering with the National Institute for Health Research (NIHR) and working with colleagues in several UK universities, and the NHS UK-wide.
Three out of four people with heart failure could be diagnosed sooner, potentially improving quality of life and reducing costs to the healthcare system.
29 November 2021
Researchers from the University of Oxford have today reported that only 1 in 4 people diagnosed with heart failure received a simple, recommended blood test that could have resulted in an earlier diagnosis at a more treatable stage.
Designing and implementing an educational framework for paramedics rotating into primary care
18 November 2021
Georgette Eaton shares an overview of her research as part of her NIHR Doctoral Research Fellowship focusing on the employment of paramedics in primary care.
Department Researchers work highlighted at NCRI festival: Fewer cases of children’s cancer picked up during COVID pandemic
12 November 2021
A study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic. The research, presented at the NCRI Festival, also shows that children who were diagnosed with cancer during the first wave of the pandemic were more likely to have been admitted to intensive care prior to their diagnosis.
Department Researchers work highlighted at NCRI festival: New symptoms identified that could help doctors diagnose pancreatic cancer
8 November 2021
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms – feeling thirsty and having dark urine – in a study presented today (Monday, 8th Jan) at the NCRI Festival.
PCR cycle threshold may be key to predicting infectiousness of people with asymptomatic and pre-symptomatic COVID-19, suggests new review.
1 November 2021
An international team of researchers, led from Centre for Evidence-based Medicine based in the Nuffield Department of Primary Care Health Sciences, University of Oxford, and funded by the World Health Organization and the National Institute for Health Research School for Primary Care Research, have today announced the findings from the most complete analysis of high-quality covid transmission studies in asymptomatic and pre-symptomatic people to date.
Department awarded funding to complete community COVID-19 antiviral trial
26 October 2021
Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.
COVID-19 infection has greater risk of causing very rare neurological events than vaccines
25 October 2021
Researchers from across the UK, led by the University of Oxford, have today reported on the risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.